Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00983645 · ClinicalTrials.gov registry record · Phase 4
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
A Phase 4 study, sponsored by Loma Linda University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00983645 is a Phase 4 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 15 participants.
The verdict
NCT00983645, a Phase 4 study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.
Interventions
- DRUG Prograf
- DRUG Neoral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2004-10 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00983645
The ClinicalTrials.gov registry entry for NCT00983645 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prograf is the first listed.
NCT00983645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00983645 about?
NCT00983645 is a clinical study titled "A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity". This study aims to compare outcomes in renal transplant recipients in the hispanic population based on their immunosuppressant regimens.
What is the current status of trial NCT00983645?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2004-10. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00983645?
The interventions under investigation include: Prograf (DRUG), Neoral (DRUG).
Who is sponsoring clinical trial NCT00983645?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.